{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-008658","form_type":"8-K","ticker":"MBOT","cik":"0000883975","company_name":"Microbot Medical Inc.","filed_at":"2026-03-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:37.910887+00:00","generated_at":"2026-05-15T22:28:10.606557+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.5,"confidence":"high","headline":"Microbot Medical confirms no business disruption amid Middle East events, progresses LIBERTY commercial launch","bullets":["No business disruption in USA or Israel; all personnel operational, lead manufacturing partner fully functional.","LIBERTY system received FDA clearance; limited market release began late 2025; full market release at SIR April 2026.","Hired additional U.S. sales representatives and a Director of Health Economics and Outcomes Research (HEOR) for commercial expansion.","Sufficient U.S. inventory maintained; building additional stock via third-party logistics partner for anticipated demand."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-008658","json":"https://secwatch.observer/filing/0001493152-26-008658.json","markdown":"https://secwatch.observer/filing/0001493152-26-008658.md","text":"https://secwatch.observer/filing/0001493152-26-008658.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/883975/000149315226008658/0001493152-26-008658-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/883975/000149315226008658/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T22:28:10.606557+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}